Demographic, clinical, and social characteristics of patients receiving concurrent TB/HIV treatment in selected THAT’SIT clinics, South Africa, 2008–2010 (N = 1,252).

Ernesha Webb Mazinyo (3149211)
Lindsay Kim (3149202)
Sikhethiwe Masuku (3149196)
Joey L. Lancaster (3149208)
Ronel Odendaal (397858)
Margot Uys (3149199)
Laura Jean Podewils (439228)
Martie L. Van der Walt (3149205)

Publication date

July 2016

DOI

10.1371/journal.pone.0159317.t001

Abstract

<p>BMI = body mass index; TB = tuberculosis; IRZE = isoniazid, rifampin, pyrazinamide, ethambutol; DOT = directly observed therapy; WHO = World Health Organization; HIV = human immunodeficiency virus; ARV = antiretroviral; D4T/3TC/EFV = stavudine, lamivudine, efavirenz; D4T/3TC/NVP = stavudine, lamivudine, nevirapine.</p

Extracted data

We use cookies to provide a better user experience.

Data Protection

Demographic, clinical, and social characteristics of patients receiving concurrent TB/HIV treatment in selected THAT’SIT clinics, South Africa, 2008–2010 (N = 1,252).

Abstract

Extracted data

Demographic, clinical, and social characteristics of patients receiving concurrent TB/HIV treatment in selected THAT’SIT clinics, South Africa, 2008–2010 (N = 1,252).

Abstract

Extracted data

Related items

Related items